| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine I, University of Freiburg Medical Center, Freiburg [H-J. G., M. A. B., R. B., R. H. M., F. H.], and German Collection of Microorganisms and Cell Cultures [H-G. D.], Braunschweig, Germany
In the present study, we show by Northern blot analysis and enzyme linked immunosorbent assay that the Hodgkin's disease (HD)-derived cell lines HDLM-2 and KM-H2 express a variety of cytokine genes either constitutively or upon induction with phorbol ester 12-O-tetrade-canoylphorbol-13-acetate. Cytokine genes expressed by HD-derived lines include granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, interleukin (IL)-1-
, IL-3, IL-5, IL-6, IL-8, leukemia inhibitory factor, tumor necrosis factor-
, tumor necrosis factor-ß, and transforming growth factor-ß, while transcripts and the corresponding proteins for granulocyte-CSF, IL-1-ß, IL-2, IL-4, IL-7, IL-10, and the JE/macrophage chemoattractant and activating factor gene were not detectable in cytoplasmic RNA and culture supernatants obtained from both lines. In addition, IL-2 receptor (R) p55 and macrophage-CSF R (c-fms) genes were expressed by both lines. HDLM-2, but not KM-H2 cells, exhibited the IL-6 R p80 and the IL-2 R p75 chain. Analysis of nuclear proteins that bind to oligonucleotides containing the consensus sequences of the transcription factors activation protein 1, nuclear factor (NF)
B, and NFAT 1 revealed a pattern for HD lines resembling that of activated T-cells: HDLM-2 and KM-H2 cells constitutively expressed NF binding to the NF of activated T-cells (type 1), previously described to be T-cell specific. In addition, NF
B-binding proteins obtained from both lines showed, in electrophoretic mobility shift assays, the same migration pattern as T-cell-derived proteins but differed from monocyte- and B-cell-derived proteins. UV cross-linking experiments confirmed that NF
B-binding proteins of Mr 85,000, 75,000, and 50,000/55,000 were detectable in nuclear extracts obtained from T-cells and both HD lines, while monocytes and B-cells displayed the Mr 50,000/55,000 and 75,000 NF
B complex only. Both HD lines also constitutively expressed transcripts for c-fos and c-jun, which are involved in heterodimeric formation of the transcription factor activation protein 1, as well as for the NF
B/KBF1 gene.
1 Supported by the Deutsche Krebshilfe.
2 To whom requests for reprints should be addressed, at Department of Internal Medicine I, University of Freiburg Medical Center, Hugstetter Str. 55, D-7800 Freiburg i.Br., Germany.
Received 12/10/91. Accepted 4/ 6/92.
This article has been cited by other articles:
![]() |
M. Kawakami, K. Kawakami, M. Kioi, P. Leland, and R. K. Puri Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model Blood, May 1, 2005; 105(9): 3707 - 3713. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Laouar, I. N. Crispe, and R. A. Flavell Overexpression of IL-7R{alpha} provides a competitive advantage during early T-cell development Blood, March 15, 2004; 103(6): 1985 - 1994. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watanabe, Y. Ogawa, K. Ito, M. Higashihara, M. E. Kadin, L. J. Abraham, T. Watanabe, and R. Horie AP-1 Mediated Relief of Repressive Activity of the CD30 Promoter Microsatellite in Hodgkin and Reed-Sternberg Cells Am. J. Pathol., August 1, 2003; 163(2): 633 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, E. Y. Choi, Y. K. Shin, T. J. Kim, D. H. Chung, S. I. Chang, N. K. Kim, and S. H. Park Generation of Cells With Hodgkin's and Reed-Sternberg Phenotype Through Downregulation of CD99 (Mic2) Blood, December 1, 1998; 92(11): 4287 - 4295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Matsumoto, H. Matsumoto, M. Seki, M. Hata, Y. Asano, S. Kanegasaki, R. L. Stevens, and M. Hirashima Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes J. Biol. Chem., July 3, 1998; 273(27): 16976 - 16984. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |